Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Weijian Guo
Observed names:
W J Guo,
Wei-Jian Guo,
Wei-jian Guo
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Chinese Academy of Sciences,
Fudan University,
XinHua Hospital,
Ruijin Hospital,
Fudan University Shanghai Cancer Center,
Shanghai Institutes for Biological Sciences
show all 7
OpenAlex ID:
A5101237915
Prediction of Pancreatic Cancer by Serum Biomarkers Using Surface-Enhanced Laser Desorption/Ionization-Based Decision Tree Classification
2005
·
Yun Yu
, Sheng Chen
, et al.
·
Oncology
·
95
First‐line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis
2022
·
Tianshu Liu
, Yuxian Bai
, et al.
·
International Journal of Cancer
·
81
PDF
Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial
2024
·
Feng Wang
, Lin Shen
, et al.
·
Nature Medicine
·
45
Expression and clinical role of NF45 as a novel cell cycle protein in esophageal squamous cell carcinoma (ESCC)
2014
·
Sujie Ni
, Junya Zhu
, et al.
·
Tumor Biology
·
40
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study
2023
·
Jin Li
, Shukui Qin
, et al.
·
BMC Medicine
·
37
PDF
Efficacy, Safety, and Immunogenicity of HLX04 Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatment for Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase III Study
2021
·
Shukui Qin
, Jin Li
, et al.
·
BioDrugs
·
30
PDF
Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer
2019
·
Jieyun Zhang
, Zhe Gong
, et al.
·
Japanese Journal of Clinical Oncology
·
30
PDF
COX-2-765G>C Polymorphism Increases the Risk of Cancer: A Meta-Analysis
2013
·
Xiao-feng Wang
, Ming-zhu Huang
, et al.
·
PLoS ONE
·
25
PDF
Correction to: Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study
2018
·
Xinyang Liu
, Shukui Qin
, et al.
·
Journal of Hematology & Oncology
·
11
PDF
Induction Chemotherapy Followed by Primary Tumor Resection Did Not Bring Survival Benefits in Colon Cancer Patients With Asymptomatic Primary Lesion and Synchronous Unresectable Metastases
2022
·
Mingzhu Huang
, Ya’nan Yang
, et al.
·
Frontiers in Oncology
·
9
Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer
2022
·
Xiao-Yin Zhao
, Xin Liu
, et al.
·
Frontiers in Oncology
·
6
Angiotensin-converting enzyme insertion/deletion polymorphism and gastric cancer: a systematic review and meta-analysis.
2015
·
Lu Gan
, Xinyang Liu
, et al.
·
PubMed
·
5
Effect of CAO released from MS-CAO on human hepatoma cell line SMMC-7721
2003
·
Wan-Yin Wu
, Wei-Jian Guo
, et al.
·
World Chinese Journal of Digestology
·
5
Chinese Medicine Prolongs Overall Survival of Chinese Patients with Advanced Gastric Cancer: Treatment Pattern and Survival Analysis of a 20-Year Real-World Study
2024
·
Ni-da Cao
, Xiao-hong Zhu
, et al.
·
Chinese Journal of Integrative Medicine
·
4
QL1203 vs placebo plus mFOLFOX6 as first-line therapy in RAS wild-type, metastatic colorectal cancer (mCRC): Interim analysis (IA) of a multicenter, randomized, double-blinded, parallel, phase 3 trial.
2025
·
Weijian Guo
, Yusheng Wang
, et al.
·
Journal of Clinical Oncology
·
2
Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.
2001
·
J Li
, L Z Xu
, et al.
·
PubMed
·
2
Evaluating the efficacy of fruquintinib versus regorafenib and trifluridine/tipiracil in treating advanced metastatic colorectal cancer: A match-adjusted indirect comparison.
2025
·
Shukui Qin
, Jin Li
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Envafolimab in combination with lenvatinib and albumin paclitaxel for previously treated advanced GEJ adenocarcinoma: Latest analysis of a phase II, two-cohort study.
2025
·
Xiaoying Zhao
, Weijian Guo
, et al.
·
Journal of Clinical Oncology
·
1
Iparomlimab (QL1604) in patients (pts) with unresectable/metastatic deficient mismatch repair (dMMR)/microsatellite instability high (MSI-H) solid tumors: A single-arm, multicenter, pivotal, phase II study.
2024
·
Weijian Guo
, Feng Bi
, et al.
·
Journal of Clinical Oncology
·
1
[Effects of arsenic trioxide and ATRA on PLZF-RARalpha-positive U937 leukemic cells].
2007
·
Si-yu Chen
, Li-heng Ma
, et al.
·
PubMed
·
1
Envafolimab in combination with lenvatinib and albumin paclitaxel for previously treated advanced gastric/gastroesophageal junction adenocarcinoma: Preliminary analysis of a phase II, two-cohort study.
2024
·
Xiaoying Zhao
, Weijian Guo
, et al.
·
Journal of Clinical Oncology
Unbalance Measurement Traceability
2023
·
Weijian Guo
·
Mechanisms and machine science
Severe Loss of Visceral Fat and Skeletal Muscle After Chemotherapy Predict Poor Prognosis in Metastatic Gastric Cancer Patients Without Gastrectomy
2019
·
Wanjing Feng
, Mingzhu Huang
, et al.
·
SSRN Electronic Journal
Longitudinal study of symptom distress with adjuvant chemotherapy in colon cancer
2010
·
Jian Hua
, Qiu-qin Peng
, et al.
·
Zhonghua xiandai huli zazhi
Study on the inhibition of drug-resistant human breast cancer cells with exogenous tumor necrosis faclor-α gene therapy
2002
·
Weijian Guo
·
Zhonghua shiyan waike zazhi
Show more works
View as search
Works count:
25
Citation count:
431
H-index:
9
I10-index:
9
Year
Topic
Type